Sharon is a leading specialist in international business development within the healthcare industry (Biopharma, Medical Devices, Digital Health, Health IT).
Moved by the brilliant, innovative, and resilient ability of Israeli start-ups to contribute to the world’s most pressing challenges, Sharon was inspired to help accelerate the growth of Israeli technologies and connect them with the right partners and investors.
Star Tree Ventures was born.
Prior to founding Star Tree Ventures, Sharon was a founder and managed the business development and strategic planning of Orphan Technologies Ltd, a company focused on research and development of innovative therapies for rare, life-threatening diseases with unmet medical needs. In this role, she conducted the due-diligence on hundreds of early-stage healthcare products and led several licensing transactions.
Prior to that, Sharon was an Associate Consultant at Defined Health, a leading Business Development consulting company in New Jersey. In that capacity, she provided strategic advice, support, and due-diligence to leading global biopharmaceutical companies, focused on the scientific, clinical, regulatory, and commercial outlook for their products.
Sharon also served as Research Analyst at Science and Technology Ventures, the Technology Transfer Office of Columbia University.
Sharon has evaluated and provided deep diligence on hundreds of products in dozens of indications, both for biopharmaceutical companies, as well as leading healthcare investment funds.
Sharon is a Board member at Ramot, the Technology Transfer Office of Tel Aviv University and a mentor in several Israeli accelerators.
Sharon holds a MA in Biotechnology from Columbia University and a B.Sc. Summa Cum Laude in Biology from Tel-Aviv University (Member of Special Honors Research Program).